IN PARTNERSHIP
partners, freight agents and couriers, we ensured timely delivery and continuity of the cold chain. We also provided local destruction options and worked with validated, medical translation service partners.
As a result of working with Tanner, the Phase III trial was planned and executed within the specified timeframe and within budget. Over 3,000 packs were delivered to the clinical sites, and the biotech company has since awarded Tanner with additional programmes.
Case study II: orchestrating a complex supply chain with aggressive timelines A US-based generic pharmaceutical company contacted Tanner to help procure and deliver 165 packs of a branded EU cardiology product. To meet research and development requirements, the products needed to be procured from three different lots to support the Phase III, global study. Additionally, the company required near-term delivery within a three-week time frame, with the final destination being India. Due to the challenging logistics and short lead time, we used our speciality EU supply network to source the three lots, securing the needed product against an aggressive timeline. We supplied product from Spain, Germany and Czech Republic, along with the relevant documentation, for importation into India. Understanding the mechanisms and timing required to obtain the import permit, we arranged for storage of the three lots in a warehouse based in Austria, until the customer was ready to ship. Per GDP requirements, we ensured the product was kept within its temperature range during storage and the outbound shipment to India. Tanner’s experienced team was not only able to provide the pharmaceutical company with a rapid turnaround time, but a solution that met all requirements and was cost-effective. Our flexibility enabled the collation of three lots in a central warehouse, thus combining three shipments into one and saving on overall distribution costs. Additionally, our GDP experience allowed us to manage all logistical aspects in an efficient and compliant manner, ensuring integrity of products from the sourcing point to their final destination. Our team kept to the rigid project timelines to ensure there were no costly delays
36 | Clinical Trial Supply Handbook
to start the R&D work, ultimately saving our partner seven days on their original timeline.
Case study III: maintaining control and visibility over global requests for drug products A generic company was receiving international inquiries for its drug portfolios spanning several therapeutic areas. Managing these requests and accompanying logistics while minimising exposure to risk had become difficult due to a lack of internal resources and regulatory knowledge. Tanner developed and implemented a system
to review and approve requests. We liaised with local authorities to ensure all country-specific requirements were met, and identified and managed all import/export and regulatory and compliance guidelines. Tanner oversaw distribution and storage of products according to EU-GDP standards using in-house and outsourced capabilities.
As a result, critical medications were supplied to 23 countries. The company has been able to maintain complete visibility to all requests and receive reports on outcomes data. Additionally, this gatekeeper function allows the company to devote internal resources to functions that drive key players, and increase the accuracy of manufacturing forecasts.
Why Tanner CTS? • Local market know-how: We have more than 20 years’ experience in the clinical supply industry, with customers in five continents.
• Worldwide procurement capabilities: Tanner provides reference-listed drugs and comparators in countries worldwide, with access ranging from generics to
• Commitment to success: Tanner is a solution-oriented company with the grit and ethos needed to make a difference every day for patients and customers worldwide.
• Innovative and flexible: Having worked with a variety of partners from biotechs, generic and large pharma companies to CROs and CDMOs, the Tanner team never applies a services in accordance with the needs of each customer.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
